Andrew Raubitschek
Researcher Next ID · RN-015961
Researcher · Medicine
Institute of Neuroimmunology of the Slovak Academy of Sciences
, Slovakia
- Works count
- 219
- Citation count
- 11,654
- H-index
- 59
- i10-index
- 127
Research interests
Publications
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
Blood · 2012 · 10.1182/blood-2011-10-387969
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
Nature Biotechnology · 2009 · 10.1038/nbt.1564
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
Blood · 2008 · 10.1182/blood-2007-12-128843
Specific Recognition and Killing of Glioblastoma Multiforme by Interleukin 13-Zetakine Redirected Cytolytic T Cells
Cancer Research · 2004 · 10.1158/0008-5472.can-04-0454
Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+B-Cell Non-Hodgkin's Lymphoma
Journal of Clinical Oncology · 1999 · 10.1200/jco.1999.17.12.3793
Current projects
No projects listed.